Secondary outcomes included cardiovascular mortality, all-cause mortality, non-fatal myocardial infarction, non-fatal stroke, hospitalisation for heart failure, and adverse events
How Genetic Factors Influence Your Semaglutide Safety Profile Genetic variants in GLP1R (the semaglutide receptor gene), FTO (appetite regulation), and MC4R (metabolic signaling) create individual differences in how bodies respond to dosing
In April 2026, Nora Volkow and Xu reviewed reports of lower rates of alcohol-related events, reduced opioid overdose risk, and associations extending to nicotine, cocaine, cannabis, and other substances
A 2026 meta-analysis of over 1,300 people found the strongest anti-aging benefit from peptides actually came from oral supplements, not the serums most people are applying to their face